Are H1 and H3 haplotypes of endothelial protein C receptor (PROCR) an important factor in contracting COVID‐19?. Issue 10 (24th June 2022)

• Record Type: Journal Article
• Authors: Ceylan, Mehmet Reşat; Kankılıç, Nazım; Öz, Özlem
• Is Part Of: Journal of medical virology. Volume 94:Issue 10(2022)
• Page Start: 4803
• Page End: 4808
• Publication Date: 2022-06-24
• Subjects: COVID‐19 -- PROCR H1 -- PROCR H3 -- sEPCR; Virology -- Periodicals; 616
• DOI: 10.1002/jmv.27938
• Languages: English
• ISSNs: 0146-6615

Abstract

Abstract: The development of cardiovascular disease shows increase after contracting coronavirus 2019 (COVID‐19) disease and myocardial damage is observed in patients who have had the disease severely. The relationship between genetic cardiovascular risk factors with COVID‐19 infection was investigated in our study. One hundred thirty‐five patients, 27 of whom were COVID‐19 (−) and 108 were COVID‐19 (+) patients, were included in the study. Patients were divided into three groups ([COVID‐19 [−], COVID‐19 [+] asymptomatic, and COVID‐19 [+] symptomatic + patients with pulmonary involvement]). Genetic cardiovascular risk factors were examined in blood samples taken from the patients with new generation sequencing analysis. In the clinical classification, there were no significant differences between the three groups in fibrinogen beta chain—455G>A, human platelet antigen 1 (HPA1b)/platelet receptor GPIIIa/(ITGB3) (HPA1a/b; GpIIIa; integrin beta 3 L33P), ACE I/D, AGT (M268T), AGTR1 (1166A>C), Apo E (E2/E3/E4) (rs7412, rs429358), eNOS (786T>C), eNOS (894G>T) genes ( p > 0.05). However, significant differences were observed in PROCR H3 haplotype/G (endothelial protein C receptor gene [EPCR] 4600A>G [A3 haplotype]), PROCR H1 haplotype/C (EPCR 4678G>C [A1 haplotype]) genes ( p < 0.05). When COVID‐19 (+) and COVID‐19 (−) groups were compared, it was observed that the infection was more common in people with PROCR H1 haplotype/C and PROCR H3 haplotype/G genotypes ( p < 0.05). PROCR H1 and PROCR H3 haplotypes may be an important factor in contracting COVID‐19 disease. In people with COVID‐19 disease, revealing PROCR genetic differences and measuring sEPCR levels will be beneficial in the follow‐up of the disease.